This message was sent to ##Email##
|
|
|
|
|
| |
| ACS CANCER PROGRAMS UPDATES |
ACS
Lymphovascular Invasion, NAACCR Data Item #1182, indicates the presence or absence of tumor cells in lymphatic channels (not lymph nodes) or blood vessels within the primary tumor as noted microscopically by the pathologist.
Review the primary site, histology and Schema ID for this record, and then follow the coding instructions in STORE. Assign codes for Lymphovascular Invasion, NAACCR Data Item # 1182, based on the absence or presence of lymphovascular invasion as described in the medical record from the checklist or synoptic report, pathology report or a physician’s statement, in that order.
READ MORE
ACS
April 7–9, 2019 – Rosemont (Chicago), Illinois
The 2019 Cancer Programs Cluster Workshops will be three individual one-day workshops on consecutive days, in one location, for your convenience. You may attend just one workshop or all three. Sign up here for further information as it becomes available.
The 2019 Commission on Cancer (CoC) annual accreditation fees will remain the same as in 2018 for all program categories, except Integrated Network Cancer Programs (INCPs). The National Accreditation Program for Breast Centers (NAPBC) and National Accreditation Program for Rectal Cancer (NAPRC) fees will also stay the same in 2019.
READ MORE
|
Promoted by
|
|
|
|
 |
Clinical Research Program
As mentioned in prior communications, the 2018 DCIS Special Study opened July 16. We invite you to visit the 2018 Special Study on DCIS SharePoint site, which will house all materials you will need to participate in the study. We have created a universal login for this site; please note it is case sensitive:
Login: DCISStudy
Password: study2018.
All registrars and co-registrars will be able to access and download materials via the SharePoint site.
READ MORE
American College of Surgeons - NAPRC
The National Accreditation Program for Rectal Cancer (NAPRC) is now accepting applications. The NAPRC was developed to ensure that rectal cancer patients receive appropriate care following a multidisciplinary approach. Programs will be evaluated on the standards and metrics outlined in The National Accreditation Program for Rectal Cancer Standards Manual 2017 (revised October 2017).
READ MORE
 |
|
Our ihcDirect® method yields a revolutionary technology that opens a spectrum of new clinical applications including intraoperative surgery. Using the Novodiax PolyHRP technology, Intraoperative IHC tests can now be completed in just 10 minutes using fresh frozen tissues.
For more details, see our
 ihcDirect® product list.
|
|
ACS
The AJCC Cancer Staging Manual is the gold standard to help the cancer patient management team determine the correct stage for patients, allowing for the most appropriate care plan.
The AJCC Cancer Staging Manual is used by physicians and health care professionals throughout the world to facilitate the uniform description and reporting of neoplastic diseases. Proper classification and staging of cancer is essential for the physician to assign proper treatment, evaluate results of management and clinical trials, and to serve as the standard for local, regional and international reporting on cancer incidence and outcome.
This corrected third printing includes the following features:
- Revised breast cancer staging system
- Revised histology codes in each chapter
- Corrected errata posted on www.cancerstaging.org through Feb. 2.
Special 25 percent discount! Expires Dec. 31.
Click here for the Springer order form.
READ MORE
|
Promoted by
|
|
|
|
 |
| HEALTH CARE NEWS AND UPDATES |
Medscape
The upside of providing cancer patients with easy access to their physicians' notes far outweighs any downside, according to a new exploratory study from a major US cancer center that has embraced the "OpenNotes" movement in medicine.
There is growing momentum to provide patients with easy access to their full electronic medical records in "real time," say the study authors, led by Narek Shaverdian, MD, a radiation oncologist who was a resident at the University of California, Los Angeles (UCLA) during the study.
READ MORE
Drug Target Review
A study comparing DNA and RNA data from Nigerian breast cancer patients to patients in a United States database found that certain aggressive molecular features were far more prevalent in tumours from Nigerian women than in black or white American women.
The study’s authors say those differences in a number of molecular features could at least partially explain disparities in breast cancer mortality for women from Nigeria, and perhaps other West African nations.
READ MORE
 |
|
Dynamic online courses from the Association of Community Cancer Centers (ACCC) offer the tools your staff needs to help patients pay for treatment—while maximizing reimbursement at your cancer program. The Financial Advocacy Boot Camp explains all aspects of financial advocacy and is a great resource for new advocates and experienced professionals. Your team will be more prepared with this online curriculum. Learn More
|
|
Healio
A smartphone app may help medical students more accurately differentiate melanomas from benign skin lesions, according to study results published in JAMA Dermatology.
The traditional method of skin cancer detection is based on ABCDE criteria. The checklist accounts for asymmetry, border irregularity, color, diameter and evolution of a lesion.
READ MORE
Cancer Network
When treating low-risk primary basal cell carcinoma (BCC), surgery and external beam radiation yield a better chance of a cure and a lower recurrence rate compared with other treatment modalities. This is the finding of a recent meta-analysis published in the Annals of Internal Medicine.
READ MORE
 |
|
Clinical Cancer Coding is hard. HLA-Global’s Horizon uses advanced AI and Machine Learning to make the hard easy. Horizon has an average accuracy of 97%+ all of the time, works 24X7, costs 50% less than manual coders and continually learns. And it handles the new 2018 standards. For further information visit www.hla-global.com.
|
|
WebMD
If you come from a large family, you may have a lower risk of cancer, a new study suggests.
Researchers analyzed data from 178 countries and found that people from larger families were less likely to get cancer than those from smaller families.
READ MORE
Medical Xpress
Dr. Tasuku Honjo won the 2018 Nobel Prize in physiology or medicine for discovering the immune T-cell protein PD-1. This discovery led to a set of anti-cancer medications called checkpoint inhibitors, one of the first of which was nivolumab (Opdivo).
READ MORE
The Conversation
Many cancer patients could soon be spared the unnecessary side effects of chemotherapy after having surgery to remove their tumour. A blood test being trialled at more than 40 hospitals across Australia and New Zealand aims to detect whether there are any cancer cells remaining in the body after surgery, which could lead to the cancer returning.
READ MORE
ScienceDaily
For the first time ever, Mount Sinai researchers have identified a protein as a marker that can indicate whether a cancer patient will develop a recurrence of lethal, metastatic cancer, according to a clinical study published in Breast Cancer Research in October. The researchers found that when cells from a breast cancer patient's original tumor metastasized into the patient's bone marrow with none, or only a small amount, of the protein NR2F1, the patients all soon died.
READ MORE
| IMPORTANT DATES AND DEADLINES |
|
Missed last week's issue? See which articles your colleagues read most.
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
The Brief
Connect with AJCC
Connect with CoC
Connect with NAPBC
Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version
Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit
Ashley Harrington, Senior Content Editor, 469-420-2642 | Contribute news
Disclaimer: The Brief is a digest of news selected for the Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC), both quality programs of the American College of Surgeons, from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Cancer Programs do not endorse any of the advertised products and services. Opinions expressed in the articles are those of the authors and not of the American College of Surgeons, and the Cancer Programs.
American College of Surgeons
633 N Saint Clair Street | Chicago, IL, 60611-3211 | 800-621-4111 | Contact Us
Learn how to add us to your safe sender list so our emails get to your inbox. |
|
| |
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
features posts on the industry, careers and more:
